TC Biopharm (Holdings) Plc reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was GBP 0.98933 million compared to GBP 0.98933 million a year ago. Net income was GBP 0.512658 million compared to net loss of GBP 2.65 million a year ago.

Basic earnings per share from continuing operations was GBP 0.93 compared to basic loss per share from continuing operations of GBP 6.79 a year ago. Diluted earnings per share from continuing operations was GBP 0.76 compared to diluted loss per share from continuing operations of GBP 6.79 a year ago.